CT-721, a Potent Bcr-Abl Inhibitor, Exhibits Excellent In Vitro and In Vivo Efficacy in the Treatment of Chronic Myeloid Leukemia.
Sun Y, Zhao N, Wang H, Wu Q, Han Y, Liu Q, Wu M, Liu Y, Kong F, Wang H, Sun Y, Sun D, Jing L, Tang G, Hu Y, Xiao D, Luo H, Han Y, Peng Y.
Sun Y, et al. Among authors: zhao n.
J Cancer. 2017 Aug 23;8(14):2774-2784. doi: 10.7150/jca.18731. eCollection 2017.
J Cancer. 2017.
PMID: 28928866
Free PMC article.